Hain Lifescience specializes in advanced molecular diagnostics, utilizing their proprietary Liquid Array® technology to enhance the detection and differentiation of various pathogens. This technology supports multiplex PCR tests, allowing for the simultaneous identification of multiple pathogens from a single sample. For instance, their Liquid Array® platform is employed in tests for sexually transmitted infections, gastrointestinal pathogens, and nontuberculous mycobacteria, enabling rapid and reliable results. The FluoroType® Mycobacteria assay exemplifies this capability, providing differentiation of 32 clinically relevant nontuberculous mycobacteria and the M. tuberculosis complex in a single reaction, significantly streamlining the diagnostic process.

In addition to the Liquid Array® technology, Hain Lifescience offers the FluoroCycler® XT, an innovative instrument designed to support their multiplex assays. This system integrates DNA extraction and PCR setup, facilitating efficient amplification and detection of target pathogens. The FluoroType® technology, which employs fluorescence-labeled probes, further enhances diagnostic reliability by allowing specific amplification and detection within the same device. Overall, Hain Lifescience's technologies are geared towards improving the speed and accuracy of pathogen detection, which is crucial for effective disease management and treatment.

Germany

Hain Lifescience GmbH is a manufacturer and distributor of in-vitro diagnostics based in Nehren in the district of Tübingen.

Hain Lifescience

Company Details